Balchem (BCPC) Common Equity (2010 - 2026)

Balchem (BCPC) has reported Common Equity for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity rose 2.72% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 2.72% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 9.35% from the prior year.
• Common Equity was $1.3 billion for Q2 2026 at Balchem, up from $1.3 billion in the prior quarter.
• Over five years, Common Equity peaked at $1.3 billion in Q2 2026 and troughed at $873.7 million in Q1 2022.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity increased 0.77% in 2022 and gained 14.82% in 2024, its largest moves.
• Over 5 years, Common Equity stood at $938.3 million in 2022, then advanced by 12.33% to $1.1 billion in 2023, then increased by 9.1% to $1.1 billion in 2024, then grew by 9.35% to $1.3 billion in 2025, then grew by 3.58% to $1.3 billion in 2026.
• The last three Common Equity figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.